Notice of Intent To Grant Exclusive Patent License; Drug Risk Solutions, LLC, 54908 [05-18535]

Download as PDF 54908 Federal Register / Vol. 70, No. 180 / Monday, September 19, 2005 / Notices Dated: September 12, 2005. I.C. Le Moyne Jr., Lieutenant, Judge Advocate General’s Corps, U.S. Navy, Alternate Federal Register Liaison Officer. [FR Doc. 05–18538 Filed 9–16–05; 8:45 am] Dated: September 12, 2005. I.C. Le Moyne Jr., Lieutenant, Judge Advocate General’s Corps, U.S. Navy, Alternate Federal Register Liaison Officer. [FR Doc. 05–18537 Filed 9–16–05; 8:45 am] BILLING CODE 3810–FF–P BILLING CODE 3810–FF–P DEPARTMENT OF DEFENSE DEPARTMENT OF DEFENSE Department of the Navy Department of the Navy Meeting of the U.S. Naval Academy Board of Visitors Notice of Intent To Grant Exclusive Patent License; Drug Risk Solutions, LLC AGENCY: Department of the Navy, DOD. Notice of partially closed meeting. ACTION: The U.S. Naval Academy Board of Visitors will meet to make such inquiry, as the Board shall deem necessary into the state of morale and discipline, the curriculum, instruction, physical equipment, fiscal affairs, and academic methods of the Naval Academy. The meeting will include discussions of personnel issues at the Naval Academy, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. The executive session of this meeting will be closed to the public. SUMMARY: The open session of the meeting will be held on Tuesday, September 20, 2005, from 8 a.m. to 10:30 a.m. The closed Executive Session will be held on Tuesday, September 20, 2005, from 10:30 a.m. to 12:15 p.m. DATES: The meeting will be held in 385 Russell Senate Office Building, Washington, DC 20510. ADDRESSES: FOR FURTHER INFORMATION CONTACT: Lieutenant Commander Marc D. Boran, Executive Secretary to the Board of Visitors, Office of the Superintendent, U.S. Naval Academy, Annapolis, MD 21402–5000, 410–293–1503. This notice of meeting is provided per the Federal Advisory Committee Act (5 U.S.C. App. 2). The executive session of the meeting will consist of discussions of personnel issues at the Naval Academy and internal Board of Visitors matters. Discussion of such information cannot be adequately segregated from other topics, which precludes opening the executive session of this meeting to the public. Accordingly, the Secretary of the Navy has determined in writing that the meeting shall be partially closed to the public because it will be concerned with matters listed in section 552b(c)(2), (5), (6), (7) and (9) of title 5, United States Code. SUPPLEMENTARY INFORMATION: VerDate Aug<31>2005 15:48 Sep 16, 2005 Jkt 205001 Department of the Navy, DOD. ACTION: Notice. AGENCY: SUMMARY: The Department of the Navy hereby gives notice of its intent to grant to Drug Risk Solutions, LLC, a revocable, nonassignable, exclusive license to practice in the field of laboratory and ‘‘on site’’ analysis of human hair, other keratinized structures, blood, urine and saliva for drugs of abuse in the United States and certain foreign countries, the Government-owned inventions described in U.S. Patent No. 5,183,740: Flow Immunosensor Method and Apparatus, Navy Case No. 71,694.//U.S. Patent No. 5,354,654: Lyophilized Ligand-Receptor Complexes for Assays and Sensors, Navy Case No. 75,239.// U.S. Patent No. 6,020,209: Microcapillary-Based Flow-Through Immunosensor and Displacement Immunoassay Using the Same, Navy Case No. 78,211.//U.S. Patent No. 6,245,296: Flow Immunosensor Apparatus, Navy Case No. 74,399.//U.S. Patent No. 6,323,042: MicrocapillaryBased Flow-Through Immunosensor and Displacement Immunoassay Using the Same, Navy Case No. 80,164.//U.S. Patent No. 6,750,031: Displacement Assay on a Porous Membrane, Navy Case No. 77,298.//U.S. Patent No. 6,808,937: Displacement Assay on a Porous Membrane, Navy Case No. 83,243 and any continuations, divisionals or re-issues thereof. DATES: Anyone wishing to object to the grant of this license must file written objections along with supporting evidence, if any, not later than October 4, 2005. ADDRESSES: Written objections are to be filed with the Naval Research Laboratory, Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375– 5320. FOR FURTHER INFORMATION CONTACT: Ms. Jane Kuhl, Head, Technology Transfer Office, NRL Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375– PO 00000 Frm 00017 Fmt 4703 Sfmt 4703 5320, tel 202–767–3083. Due to U.S. Postal delays, please fax 202–404–7920, E-Mail: kuhl@utopia.nrl.navy.mil or use courier delivery to expedite response. (Authority: 35 U.S.C. 207, 37 CFR part 404.) Dated: September 13, 2005. I. C. Le Moyne Jr., Lieutenant, Judge Advocate General’s Corps, U.S. Navy, Alternate Federal Register Liaison Officer. [FR Doc. 05–18535 Filed 9–16–05; 8:45 am] BILLING CODE 3810–FF–P DEPARTMENT OF DEFENSE Department of the Navy Notice of Intent To Grant Exclusive Patent License; Seahawk Biosystems Corporation Department of the Navy, DOD. Notice. AGENCY: ACTION: SUMMARY: The Department of the Navy hereby gives notice of its intent to grant to Seahawk Biosystems Corporation, a revocable, nonassignable, exclusive license to practice in the fields of pathogen detection, disease and infection diagnostic testing, and genetic testing for veterinary applications (small and large animals, including equine); pathogen and toxin detection and genetic testing in food products derived from animals; pathogen and toxin detection and genetic testing in food processing; pathogen and toxin detection in, and monitoring of, public water, wastewater, and groundwater in the United States and certain foreign countries, the Government-Owned inventions described in Navy Case No. 97,198 entitled ‘‘Method for Modifying Nitride Substrates for Covalent Immobilization of Aminated Molecules’’ and any continuations, divisionals or reissues thereof. DATES: Anyone wishing to object to the grant of this license must file written objections along with supporting evidence, if any, not later than October 4, 2005. ADDRESSES: Written objections are to be filed with the Naval Research Laboratory, Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375– 5320. FOR FURTHER INFORMATION CONTACT: Ms. Jane F. Kuhl, Technology Transfer Office, NRL Code 1004, 4555, Overlook Avenue, SW., Washington, DC 20375– 5320, telephone 202–767–3083. Due to U.S. Postal delays, please fax 202–404– 7920, E-Mail: kuhl@utopia.nrl.navy.mil or use courier delivery to expedite response. E:\FR\FM\19SEN1.SGM 19SEN1

Agencies

[Federal Register Volume 70, Number 180 (Monday, September 19, 2005)]
[Notices]
[Page 54908]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-18535]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Navy


Notice of Intent To Grant Exclusive Patent License; Drug Risk 
Solutions, LLC

AGENCY: Department of the Navy, DOD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of the Navy hereby gives notice of its intent 
to grant to Drug Risk Solutions, LLC, a revocable, nonassignable, 
exclusive license to practice in the field of laboratory and ``on 
site'' analysis of human hair, other keratinized structures, blood, 
urine and saliva for drugs of abuse in the United States and certain 
foreign countries, the Government-owned inventions described in U.S. 
Patent No. 5,183,740: Flow Immunosensor Method and Apparatus, Navy Case 
No. 71,694.//U.S. Patent No. 5,354,654: Lyophilized Ligand-Receptor 
Complexes for Assays and Sensors, Navy Case No. 75,239.//U.S. Patent 
No. 6,020,209: Microcapillary-Based Flow-Through Immunosensor and 
Displacement Immunoassay Using the Same, Navy Case No. 78,211.//U.S. 
Patent No. 6,245,296: Flow Immunosensor Apparatus, Navy Case No. 
74,399.//U.S. Patent No. 6,323,042: Microcapillary-Based Flow-Through 
Immunosensor and Displacement Immunoassay Using the Same, Navy Case No. 
80,164.//U.S. Patent No. 6,750,031: Displacement Assay on a Porous 
Membrane, Navy Case No. 77,298.//U.S. Patent No. 6,808,937: 
Displacement Assay on a Porous Membrane, Navy Case No. 83,243 and any 
continuations, divisionals or re-issues thereof.

DATES: Anyone wishing to object to the grant of this license must file 
written objections along with supporting evidence, if any, not later 
than October 4, 2005.

ADDRESSES: Written objections are to be filed with the Naval Research 
Laboratory, Code 1004, 4555 Overlook Avenue, SW., Washington, DC 20375-
5320.

FOR FURTHER INFORMATION CONTACT: Ms. Jane Kuhl, Head, Technology 
Transfer Office, NRL Code 1004, 4555 Overlook Avenue, SW., Washington, 
DC 20375-5320, tel 202-767-3083. Due to U.S. Postal delays, please fax 
202-404-7920, E-Mail: kuhl@utopia.nrl.navy.mil or use courier delivery 
to expedite response.

(Authority: 35 U.S.C. 207, 37 CFR part 404.)

    Dated: September 13, 2005.
I. C. Le Moyne Jr.,
Lieutenant, Judge Advocate General's Corps, U.S. Navy, Alternate 
Federal Register Liaison Officer.
[FR Doc. 05-18535 Filed 9-16-05; 8:45 am]
BILLING CODE 3810-FF-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.